GB

Godavari Biorefineries Ltd

Q4 FY26Diversified FMCG

Godavari Biorefineries Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹243
Market cap₹1.2K Cr
P/E42.5
Updated23 Sept 2026
Read4 min read

What the Q4 FY26 call signalled

1 of 3 strong

RevenueModerate growth
MarginMargins steady
CapexCapex planned

The short version

Godavari Biorefineries expects a stronger outlook for bio-based chemicals in FY27, driven by improved competitiveness amid geopolitical tensions and higher energy costs globally. FY26 saw a profit after tax of INR 3.5 crores, a positive turnaround from a loss in FY25.

From Godavari Biorefineries Ltd's Q4 FY26 earnings-call transcript · updated 23 Sept 2026.

Revenue & Sales Performance

Moderate growth
  • Godavari Biorefineries expects a stronger outlook for bio-based chemicals in FY27, driven by improved competitiveness amid geopolitical tensions and higher energy costs globally.
  • Commissioning of the 200 KLPD grain-based distillery by June 2026 will add 60 million liters of ethanol capacity, contributing to increased volumes and profitability.
  • The company anticipates growth in ethanol sales, particularly through the ethanol blending program (EBP), which remains the main outlet, with 81% of ethanol equivalent sales in FY26 under EBP.
  • Expansion and multi-feedstock flexibility (including maize-based ethanol) will mitigate risks and enhance supply resilience, supporting volume growth.
  • Increased penetration in bio-based specialty chemicals is expected starting FY27, following debottlenecking and process optimization in FY26.

2 more points management made on revenue & sales performance

Profitability & Margins

See what Godavari Biorefineries Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • Godavari Biorefineries plans to commission a 200 KLPD grain-based distillery by June 2026, adding approximately 60 million liters of annual ethanol capacity.
  • The commissioning trials for this distillery are expected to start in June 2026, with some business beginning in Q2 FY27.
  • Future operational and profitability outlook depends on government ethanol blending program targets and prices, expected around September or October 2026.
  • The maize-based ethanol facility, part of multi-feedstock flexibility strategy, is being commissioned next month (from May 2026) to mitigate climate, policy, and feedstock risks.

2 more points management made on capital expenditure plans

Fundraising & Capital Structure

See what Godavari Biorefineries Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided transcript from Godavari Biorefineries Limited's Q4 and FY26 earnings call does not mention any specifics regarding the current or expected order book or pending orders. The discussion primarily focuses on: - Expansion plans including commissioning a 200 KLPD grain-based distillery by June 2026. - Market outlook in bio-based chemicals and ethanol blending programs. - Impact of government policies, pricing, and geopolitical factors on business.

2 more points management made on order book & pipeline

Godavari Biorefineries Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹564 Cr, net profit ₹53 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Diversified FMCG this season

  • ITC Ltd (Q4 FY26)

    21,463 crore, up 17.5% YoY (Page 43) . Key concall takeaways from ITC Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.

  • Hind. Unilever (Q4 FY26)

    1,200 crores ARR), Personal Care premium products, Home Care liquids, and Lifestyle Nutrition (Pages 7, 8, 10, 15). Key concall takeaways from Hindustan…

  • Hindustan Foods (Q4 FY26)

    Confident to achieve PAT of INR 200-220 crores for FY27, indicating 40-50% growth in PAT compared to FY26. Key concall takeaways from Hindustan Foods Ltd's Q4…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Godavari Biorefineries Ltd Q4 FY26 results?

Godavari Biorefineries expects a stronger outlook for bio-based chemicals in FY27, driven by improved competitiveness amid geopolitical tensions and higher energy costs globally. FY26 saw a profit after tax of INR 3.5 crores, a positive turnaround from a loss in FY25.

What is Godavari Biorefineries Ltd share price analysis?

Godavari Biorefineries Ltd currently shows a below-average growth signal. The stock trades at a P/E of 42.5 with a market cap of ₹1,233 Cr. Investors should review the full earnings analysis for detailed insights.

Is Godavari Biorefineries Ltd planning capital expenditure?

Godavari Biorefineries plans to commission a 200 KLPD grain-based distillery by June 2026, adding approximately 60 million liters of annual ethanol capacity.

Keep Godavari Biorefineries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.